Marshall Wace’s Praxair Inc PX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,122
Closed -$663K 1953
2018
Q3
$663K Sell
4,122
-8,817
-68% -$1.42M 0.01% 874
2018
Q2
$2.05M Buy
12,939
+742
+6% +$115K 0.03% 425
2018
Q1
$1.76M Buy
12,197
+708
+6% +$110K 0.07% 206
2017
Q4
$1.78M Sell
11,489
-917
-7% -$136K 0.07% 195
2017
Q3
$1.74M Buy
+12,406
New +$1.65M 0.08% 175
2017
Q2
Sell
-7,064
Closed -$841K 417
2017
Q1
$841K Sell
7,064
-442,749
-98% -$52.1M 0.04% 218
2016
Q4
$52.7M Buy
449,813
+445,340
+9,956% +$52.9M 0.35% 73
2016
Q3
$540K Sell
4,473
-32,073
-88% -$3.8M ﹤0.01% 795
2016
Q2
$4.11M Buy
+36,546
New +$4.15M 0.03% 432
2016
Q1
Sell
-67,712
Closed -$6.93M 1279
2015
Q4
$6.93M Buy
+67,712
New +$7.39M 0.07% 312
2015
Q3
Sell
-9,961
Closed -$1.19M 1146
2015
Q2
$1.19M Sell
9,961
-32,162
-76% -$3.92M 0.02% 568
2015
Q1
$5.08M Sell
42,123
-165,001
-80% -$20.6M 0.07% 311
2014
Q4
$26.8M Sell
207,124
-288,049
-58% -$36.5M 0.35% 75
2014
Q3
$63.9M Buy
495,173
+1,180
+0.2% +$155K 0.92% 15
2014
Q2
$65.6M Buy
493,993
+34,091
+7% +$4.47M 0.97% 19
2014
Q1
$60.2M Buy
+459,902
New +$59.6M 1.1% 11
2013
Q2
$55.7M Buy
+484,038
New +$55.1M 3.34% 8

Other funds holding PX

Marshall Wace's PX Position: Q4 2018 in Review

Marshall Wace sold out of Praxair Inc (PX) in Q4 2018, closing a stake of 4,122 shares — an estimated $663K sold.

Marshall Wace first reported a position in PX in Q2 2013 and held it in 17 quarters. The position peaked at $65.6M in Q2 2014. 6 funds tracked by Wall St. Rank hold PX as of Q4 2018.

  • Marshall Wace reported no remaining Praxair Inc position as of Q4 2018 after selling out during the quarter.
  • Marshall Wace sold 4,122 Praxair Inc shares in Q4 2018, an estimated $663K.
  • Marshall Wace first reported a position in Praxair Inc in Q2 2013 and held it in 17 quarters.
  • Marshall Wace's Praxair Inc position peaked at $65.6M in Q2 2014.
  • 6 funds tracked by Wall St. Rank held Praxair Inc as of Q4 2018.

Based on Marshall Wace's 13F filing for Q4 2018, filed 14 Feb 2019.